Welcome to CDC Stacks | Sickle cell trait and diabetes tests : what every healthcare provider should know - 33971 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Sickle cell trait and diabetes tests : what every healthcare provider should know
  • Published Date:
    8/26/15
  • Language:
    English
Filetype[PDF - 385.42 KB]


Details:
  • Corporate Authors:
    National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention) ; American Society of Hematology. ; Sickle Cell Disease Association of America.
  • Series:
    Sickle cell trait toolkit
  • Description:
    According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the hemoglobin A1C assay may be unreliable for diagnosing and monitoring diabetes and prediabetes in individuals with sickle cell trait (SCT) or other hemoglobinopathies. In order to provide the best possible care for your patients, it is important to determine their SCT status and know whether the A1C test you normally use should be replaced or supplemented with a different test.

    CS258998A

    Publication date from document properties.

  • Supporting Files:
    No Additional Files